Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease

Anthony J White1, Stephen J Duffy, Anthony S Walton

  • 1Baker Heart Research Institute and The Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia.

Insights

The MMP-3 6A allele is linked to unstable coronary syndromes. This genetic variant promotes plaque buildup and outward vessel remodeling, increasing heart attack risk.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Biomarkers in Atherosclerosis

Background:

  • Matrix metalloproteinases (MMPs) are implicated in cardiovascular disease.
  • The MMP-3 gene polymorphism (-1171, 5A/6A) is a potential predictor of unstable coronary syndromes.
  • Understanding genetic predispositions can aid in risk stratification for coronary artery disease (CAD).

Purpose of the Study:

  • To investigate the association between the MMP-3 polymorphism (-1171, 5A/6A) and coronary plaque characteristics.
  • To determine if this polymorphism predicts unstable clinical presentation in patients with coronary artery disease.

Main Methods:

  • Coronary intravascular ultrasound and angiography were used to assess plaque burden and stenosis in 40 de novo CAD patients.
  • Patients were categorized into unstable coronary syndrome (n=19) or stable angina pectoris (n=21).
  • A validation cohort (n=161) and the total population (n=201) were analyzed to confirm findings.

Main Results:

  • The MMP-3 6A allele was significantly more prevalent in patients with unstable coronary syndromes (p=0.027).
  • 6A allele carriers exhibited greater plaque burden, positive coronary remodeling, and higher plasma MMP-3 concentrations.
  • This association remained significant and independent of conventional risk factors in validation and total cohorts (p=0.007).

Conclusions:

  • The MMP-3 6A allele is associated with positive coronary remodeling and increased plaque burden.
  • Carrying the 6A allele increases susceptibility to unstable coronary syndromes in humans.
  • This polymorphism serves as a potential genetic marker for predicting adverse cardiovascular events.
Abstract

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...